Brainstorm Cell Therapeutics | BCLI - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Biogen USD 554.3M 128.2M 2026-03
Brainstorm Cell Therapeutics USD 1.39M 326K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 104.9M 13.17M 2026-03
Gilead Sciences USD 1.45B 326M 2026-03
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 46.29M 18.35M 2026-03
Mesoblast USD 28.54M 9.69M 2025-12